• Poliovirus, the causative agent of
poliomyelitis (commonly known as
polio), is a human enterovirus and
member of the family of
Picornaviridae.
• Poliovirus is composed of an
RNAgenome and a protein capsid.
• The genome is a single-
stranded positive-sense RNA
Virus genome that is about
7500 nucleotides long.
• The viral particle is about 30
nm in diameter with
icosahedral symmetry.
• Because of its short genome and
its simple composition—only RNA
and a nonenveloped icosahedral
protein coat that encapsulates it,
poliovirus is widely regarded as
the simplest significant virus.
• Poliovirus was first isolated in
1909 by Karl Landsteiner and
Erwin Popper.
• Poliovirus infects human cells by
binding to an immunoglobulin-like
receptor, poliovirus receptor (PVR))
on the cell surface.
• Interaction of poliovirus and PVR
facilitates an irreversible
conformational change of the viral
particle necessary for viral entry.
• The virus spreads from person to
person and can invade an infected
person’s brain and spinal cord,
causing paralysis (can’t move parts
of the body).
• The virus enters through the mouth
and multiplies in the throat and
gastrointestinal tract;
• Then moves into the bloodstream
and is carried to the central
nervous system where it replicates
and destroys the Motor Neuron
Cells.
• Motor neurons control the muscles
for swallowing, circulation,
respiration, and the trunk, arms,
and legs.
Poliovirus bound to a neuron receptor
• Attached to the host cell membrane,
entry of the viral nucleic acid was
thought to occur one of two ways:
a.) Via the formation of a pore in the
plasma membrane through which
the RNA is then “injected” into the
host cell cytoplasm.
b.) Or that the virus is taken up by
receptor-mediated endocytosis
Recent experimental evidence
supports the latter hypothesis
and suggests that poliovirus
binds to CD155 or PVR and is
taken up by endocytosis
• Immediately after
internalization of the particle,
the viral RNA is released.
• Released of the viral RNA
Immediately after internalization of
the particle
• The primary determinant of
infection for any virus is its ability to
enter a cell and produce additional
infectious particles.
• The presence of (PVR) Polio Virus
Receptor (CD155) is thought to
define the animals and tissues that
can be infected by poliovirus
• Poliovirus is an enterovirus.
• Infection occurs via the fecal–oral
route, meaning that one ingests the
virus and viral replication occurs in
the alimentary tract.
• Virus is shed in the feces of infected
individuals
• Poliovirus uses two key
mechanisms to evade the
immune system.
• First, it is capable of surviving
the highly acidic conditions of
the stomach, allowing the virus
to infect the host and spread
throughout the body via the
lymphatic system.
• Second, because it can replicate
very quickly, the virus overwhelms
the host organs before an immune
response can be mounted.
• Individuals who are exposed to
poliovirus, either through infection
or by immunization with polio
vaccine, develop immunity
• In immune individuals, antibodies
against poliovirus are present in the
tonsils and gastrointestinal tract
(specifically IgA antibodies) and are
able to block poliovirus replication;
IgG and IgM antibodies against
poliovirus can prevent the spread
of the virus to motor neurons of
the central nervous system.
• When poliovirus encounters
the nerve cells, the protruding
receptors attach to the virus
particle, and infection begins.
• Once inside the cell, the virus
hijacks the cell’s assembly process,
and makes thousands of copies of
itself in hours.
• The virus kills the cell and then
spreads to infect other cells.
• For every 200 or so virus particles
that encounter a susceptible cell,
only one will successfully enter and
replicate.
• In tissue culture, poliovirus enters
cells and replicates in six to eight
hours, yielding 10,000 to 100,000
virus particles per cell.
• One way the human immune system
protects itself is by producing
antibodies that engage the protein
covering of the poliovirus, preventing
the virus from interacting with
another cell.
• There are three types of poliovirus: 1,
2, and 3. Type 1 is the most virulent
and common.
• Both the Salk and Sabin
vaccines are “trivalent” that is,
active against all three virus
types.
• Type 2 poliovirus has not been
detected anywhere in the world
since 1999.
• A person who gets polio is immune
to future infection from the virus
type that caused the polio.
• Most people who get infected with
poliovirus (about 72 out of 100) will
not have any visible symptoms.
• About 1 out of 4 people with
poliovirus infection will have flu-like
symptoms that may include
• They include:
 Sore throat, Fever, Tiredness
 Nausea, Headache, Stomach pain
These symptoms usually last 2 to 5
days then go away on their own
• A smaller proportion of people with
poliovirus infection will develop other
more serious symptoms that affect the
brain and spinal cord; Including:
 Paresthesia (feeling of pins and
needles in the legs)
 Meningitis (infection of the covering
of the spinal cord and/or brain)
occurs in about 1 out of 25 people
with poliovirus infection
 Paralysis (can’t move parts of the
body) or weakness in the arms, legs,
or both, occurs in about 1 out of
200 people with poliovirus infection.
• Paralysis is the most severe symptom
associated with polio because it can
lead to permanent disability and
death.
• Between 2 and 10 out of 100 people
who have paralysis from poliovirus
infection die because the virus affects
the muscles that help them breathe.
• Even children who seem to fully
recover can develop new muscle
pain, weakness, or paralysis as
adults, 15 to 40 years later. This is
called Post-polio Syndrome.
• Note that “poliomyelitis” (or
“polio” for short) is defined as the
paralytic disease. So only people
with the paralytic infection are
considered to have the disease.
• Poliovirus only infects humans. It is
very contagious and spreads through
person-to-person contact.
• An infected person may spread the
virus to others immediately before
and about 1 to 2 weeks after
symptoms appear
• The virus lives in an infected person’s
throat and intestines.
• It enters the body through the
mouth and spreads through contact
with the feces (poop) of an infected
person and, though less common,
through droplets from a sneeze or
cough.
• You can get infected with poliovirus
if you have feces on your hands and
you touch your mouth.
• The virus can live in an infected
person’s feces for many weeks. It
can contaminate food and water in
unsanitary conditions.
• People who don’t have symptoms
can still pass the virus to others
and make them sick
• Polio vaccine protects children by
preparing their bodies to fight the
polio virus.
• Almost all children (99 children out
of 100) who get all the recommended
doses of vaccine will be protected
from polio.
• There are two types of vaccine
that can prevent polio; namely:
a.) Inactivated Poliovirus
Vaccine (IPV)
b.)
• Only IPV has been used in the
United States since 2000.
(Given as an injection in the leg or
arm, depending on the patient’s
age).
• OPV is still used throughout much
of the world.
For more Information:
abrahamdaylee25@gmail.com
adayklee@yahoo.com
Contact: 0880760020/0776782278

Polio pp

  • 2.
    • Poliovirus, thecausative agent of poliomyelitis (commonly known as polio), is a human enterovirus and member of the family of Picornaviridae. • Poliovirus is composed of an RNAgenome and a protein capsid. • The genome is a single- stranded positive-sense RNA Virus genome that is about 7500 nucleotides long. • The viral particle is about 30 nm in diameter with icosahedral symmetry.
  • 3.
    • Because ofits short genome and its simple composition—only RNA and a nonenveloped icosahedral protein coat that encapsulates it, poliovirus is widely regarded as the simplest significant virus. • Poliovirus was first isolated in 1909 by Karl Landsteiner and Erwin Popper. • Poliovirus infects human cells by binding to an immunoglobulin-like receptor, poliovirus receptor (PVR)) on the cell surface. • Interaction of poliovirus and PVR facilitates an irreversible conformational change of the viral particle necessary for viral entry.
  • 4.
    • The virusspreads from person to person and can invade an infected person’s brain and spinal cord, causing paralysis (can’t move parts of the body). • The virus enters through the mouth and multiplies in the throat and gastrointestinal tract; • Then moves into the bloodstream and is carried to the central nervous system where it replicates and destroys the Motor Neuron Cells. • Motor neurons control the muscles for swallowing, circulation, respiration, and the trunk, arms, and legs.
  • 5.
    Poliovirus bound toa neuron receptor
  • 6.
    • Attached tothe host cell membrane, entry of the viral nucleic acid was thought to occur one of two ways: a.) Via the formation of a pore in the plasma membrane through which the RNA is then “injected” into the host cell cytoplasm. b.) Or that the virus is taken up by receptor-mediated endocytosis Recent experimental evidence supports the latter hypothesis and suggests that poliovirus binds to CD155 or PVR and is taken up by endocytosis • Immediately after internalization of the particle, the viral RNA is released.
  • 7.
    • Released ofthe viral RNA Immediately after internalization of the particle
  • 8.
    • The primarydeterminant of infection for any virus is its ability to enter a cell and produce additional infectious particles. • The presence of (PVR) Polio Virus Receptor (CD155) is thought to define the animals and tissues that can be infected by poliovirus • Poliovirus is an enterovirus. • Infection occurs via the fecal–oral route, meaning that one ingests the virus and viral replication occurs in the alimentary tract. • Virus is shed in the feces of infected individuals
  • 9.
    • Poliovirus usestwo key mechanisms to evade the immune system. • First, it is capable of surviving the highly acidic conditions of the stomach, allowing the virus to infect the host and spread throughout the body via the lymphatic system. • Second, because it can replicate very quickly, the virus overwhelms the host organs before an immune response can be mounted. • Individuals who are exposed to poliovirus, either through infection or by immunization with polio vaccine, develop immunity
  • 10.
    • In immuneindividuals, antibodies against poliovirus are present in the tonsils and gastrointestinal tract (specifically IgA antibodies) and are able to block poliovirus replication; IgG and IgM antibodies against poliovirus can prevent the spread of the virus to motor neurons of the central nervous system. • When poliovirus encounters the nerve cells, the protruding receptors attach to the virus particle, and infection begins.
  • 11.
    • Once insidethe cell, the virus hijacks the cell’s assembly process, and makes thousands of copies of itself in hours. • The virus kills the cell and then spreads to infect other cells. • For every 200 or so virus particles that encounter a susceptible cell, only one will successfully enter and replicate. • In tissue culture, poliovirus enters cells and replicates in six to eight hours, yielding 10,000 to 100,000 virus particles per cell.
  • 12.
    • One waythe human immune system protects itself is by producing antibodies that engage the protein covering of the poliovirus, preventing the virus from interacting with another cell. • There are three types of poliovirus: 1, 2, and 3. Type 1 is the most virulent and common. • Both the Salk and Sabin vaccines are “trivalent” that is, active against all three virus types.
  • 13.
    • Type 2poliovirus has not been detected anywhere in the world since 1999. • A person who gets polio is immune to future infection from the virus type that caused the polio.
  • 14.
    • Most peoplewho get infected with poliovirus (about 72 out of 100) will not have any visible symptoms. • About 1 out of 4 people with poliovirus infection will have flu-like symptoms that may include • They include:  Sore throat, Fever, Tiredness  Nausea, Headache, Stomach pain These symptoms usually last 2 to 5 days then go away on their own
  • 15.
    • A smallerproportion of people with poliovirus infection will develop other more serious symptoms that affect the brain and spinal cord; Including:  Paresthesia (feeling of pins and needles in the legs)  Meningitis (infection of the covering of the spinal cord and/or brain) occurs in about 1 out of 25 people with poliovirus infection  Paralysis (can’t move parts of the body) or weakness in the arms, legs, or both, occurs in about 1 out of 200 people with poliovirus infection.
  • 16.
    • Paralysis isthe most severe symptom associated with polio because it can lead to permanent disability and death. • Between 2 and 10 out of 100 people who have paralysis from poliovirus infection die because the virus affects the muscles that help them breathe. • Even children who seem to fully recover can develop new muscle pain, weakness, or paralysis as adults, 15 to 40 years later. This is called Post-polio Syndrome. • Note that “poliomyelitis” (or “polio” for short) is defined as the paralytic disease. So only people with the paralytic infection are considered to have the disease.
  • 17.
    • Poliovirus onlyinfects humans. It is very contagious and spreads through person-to-person contact. • An infected person may spread the virus to others immediately before and about 1 to 2 weeks after symptoms appear • The virus lives in an infected person’s throat and intestines. • It enters the body through the mouth and spreads through contact with the feces (poop) of an infected person and, though less common, through droplets from a sneeze or cough. • You can get infected with poliovirus if you have feces on your hands and you touch your mouth.
  • 18.
    • The viruscan live in an infected person’s feces for many weeks. It can contaminate food and water in unsanitary conditions. • People who don’t have symptoms can still pass the virus to others and make them sick
  • 19.
    • Polio vaccineprotects children by preparing their bodies to fight the polio virus. • Almost all children (99 children out of 100) who get all the recommended doses of vaccine will be protected from polio. • There are two types of vaccine that can prevent polio; namely: a.) Inactivated Poliovirus Vaccine (IPV) b.)
  • 20.
    • Only IPVhas been used in the United States since 2000. (Given as an injection in the leg or arm, depending on the patient’s age). • OPV is still used throughout much of the world.
  • 21.